A Randomized, Double-blinded, Phase III Study of Atezolizumab Versus Placebo in Patients With Late Relapse of Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer Treated by Platinum-based Chemotherapy and Bevacizumab
Latest Information Update: 01 Jul 2024
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary) ; Carboplatin; Doxorubicin liposomal; Gemcitabine; Paclitaxel
- Indications Adenocarcinoma; Carcinoma; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms ATALANTE
- 30 Jun 2024 This trial has been completed in Austria, according to European Clinical Trials Database record.
- 23 May 2024 This trial has been completed in Belgium, according to European Clinical Trials Database record.
- 02 May 2024 This trial has been completed in Germany, according to European Clinical Trials Database record.